Phorbol esters and CAMP differentially regulate the expression of CD4 and CD8 in human thymocytes by Martinez-Valdez, Hector et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Immunology
BMC Immunology  2002,  3 Research article
Phorbol esters and CAMP differentially regulate the expression of 
CD4 and CD8 in human thymocytes
Hector Martinez-Valdez*1, Vicente Madrid-Marina2 and Amos Cohen3
Address: 1Department of Immunology, Box 178, The University of Texas MD Anderson Cancer Center, USA, 2Virologia Molecular, Centro de 
Investigacion Sobre, Enfermedades Infecciosas, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico and 3Division of Immunology/
Rheumatology, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada
E-mail: Hector Martinez-Valdez* - hmartine@mdanderson.org; Vicente Madrid-Marina - vmarina@correo.insp.mx; 
Amos Cohen - ac@sickkids.ca
*Corresponding author
Abstract
Background: Intrathymic development and selection of the T lymphocyte repertoire is restricted
by the interactions of the T cell antigen receptor and CD4 or CD8 co-receptors with self major
histocompatibility complex molecules. Positive or negative selection depends on a tight regulatory
control of CD4 and CD8 expression. Determining the intracellular signals that differentially
regulate the expression of CD4 and CD8 is important to understand the mechanisms that are
implicated in selection of single positive CD4+CD8- or CD4-CD8+.
Results: The present study shows that stimulation of human thymocytes by phorbol esters or
cAMP result in a differential regulation of CD4 and CD8 expression, both at the mRNA and cell
surface glycoprotein level.
Conclusions: The differential regulation of CD4 and CD8 gene expression suggests that the
selective activation of protein kinase C (PKC) and cAMP-dependent protein kinases (PKA) may be
required for the selection of single positive CD4+CD8- and CD4-CD8+ cells during Intrathymic
differentiation
Background
T-lymphocytes expressing the α :β  T-cell antigen receptor
(TCR) consist of two major subsets: T cells expressing the
CD4 surface glycoprotein, which are restricted by the ma-
jor hystocompatibility complex (MHC) class II proteins,
and CD8+ T cells, which interact with antigen presented
by MHC class I proteins [1]. CD4 and CD8 molecules
bind to monomorphic regions on class II and class I MHC
proteins respectively, thereby increasing the avidity in the
interaction of the TCR with antigen presenting cells [2].
An intriguing question concerns to the mechanism by
which selection and tolerance to self-components is medi-
ated in developing lymphocytes. This is particularly rele-
vant to T Lymphocytes because of their ability to
recognize antigen only if this is associated with the class I
or the class II MHC molecules [3], and also because of the
unique selection process which operates within the thy-
mus during T cell development. Early during T-cell devel-
opment in the thymic cortex, thymocytes bear both of the
T cell surface glycoproteins CD4 and CD8 and express the
α  and β  heterodimer of the TCR [4]. Compelling data have
demonstrated that CD4 and CD8 molecules participate in
the selection of MHC class I or class II restricted T cells in
the thymus. It is known that during clonal selection in the
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thymus, immature CD4, CD8 double positive cells devel-
op into single positive CD4 or CD8 cells according to the
relative affinity of their TCR to class II or class I molecules
respectively [5,6]. These immature T-cells are selected in
the thymic epithelium on the basis of their TCR interac-
tion with either class I or class II MHC molecules [7,8],
thus generating two mutually exclusive subpopulations
that are characterized by the expression of either CD4 or
CD8 glycoproteins [9]. Earlier studies in the murine sys-
tem have demonstrated that PMA and cAMP can modu-
late the expression CD4 and CD8 on developing
thymocytes [10–13]. In keeping with these findings, ex
vivo experiments with human thymocytes previously re-
ported by our group, revealed that while phorbol esters
can coordinately regulate the transcription of α  and β  TCR
during intrathymic T cell differentiation [14], cAMP selec-
tively affected the transcription of the α  and δ -TCR
[15,16]. Together the murine data and our own findings
support the hypothesis that in humans, TCR expression
and CD4, CD8 commitment and selection may be regu-
lated by the same signal-transduction pathways. Since (a)
it is generally accepted that CD4 or CD8 are physically as-
sociated to the TCR in the course of T cell activation
[17,18] and (b) it is well known that mitogen activated
protein (MAP) kinase signaling is involved in the selec-
tion of the T cell repertoire [19,20], the present study fur-
ther proposes that the PKC and PKA-mediated signaling,
which regulates TCR expression, can coordinately modu-
late the selection of CD4+CD8- and CD4-CD8+ T cells dur-
ing human intrathymic differentiation.
Results
The effect of the phorbol ester 12-tetradecanoylphorbol-
13 acetate (PMA) and exogenous cAMP on the levels of
mRNA encoding the CD4 and CD8 glycoproteins was ex-
amined in human thymocytes. Total post-Ficoll un-frac-
tionated thymocytes were incubated in the presence or the
absence of 10 nM PMA and/or 0.1 mM cAMP + 1 mM of
the phosphodiesterase inhibitor isobutylemthylxnthine
(IBMX). The fundamental reasons for the design of our ex-
vivo experiments are three-fold: (a) The need to evaluate
intrathymic differentiation as close as it could be physical-
ly possible to an in vivo model; (b) We sought to perform
the experiments on "untouched" cells with the least of
manipulations. In purifying thymocyte subsets, there is a
risk that the antibodies used for the selection of the DP
subset can stimulate cells through a TCR-like signaling,
thus masking the read-out of the experimental stimuli
and; (c) At least 80% of thymocytes are double positive
(DP) cells. Therefore the contribution of single positive
(SP) cannot be a concern. After 3.0 h incubation RNA was
extracted and analyzed for CD4 and CD8 expression by
northern blot hybridizations. As shown in Fig. 1, PMA
caused a marked decrease in the levels of both CD4 and
CD8 mRNAs, whose constitutive expression is high in de-
veloping thymocytes. In contrast, cAMP selectively de-
creased CD8 mRNA levels. On the other hand, apoptosis
was ruled out as a mechanism to explain the differential
down-regulation of CD4 and CD8 by PMA and cAMP, on
the grounds of two independent observations: (a) After a
maximum of 4.0 hr incubation with either PMA or cAMP+
IBMX the cell viability was the same as the untreated con-
trols (usually between 90–95%); (b) Treatment with dex-
amethasone, which is a known pro-apoptotic molecule
did not have any effects on the expression of either CD4
or CD8 (data not shown) and; (c) As demonstrated earlier
in the murine system, TCR engagement of CD4+CD8+ in-
duces positive selection but not apoptosis [12]
To further investigate whether the effect of PMA on CD4
and CD8 expression is consistent with the activation of
protein kinase C (PKC), we examined structurally distinct
phorbol esters that either have or lack the capacity to acti-
vate PKC, for their effectiveness to modulate the levels of
CD4 and CD8 mRNAs. As shown in Fig. 2, the α -configu-
ration of the phorbol ester that lacks the ability to activate
PKC [21] had no effect on the expression of CD4 and
CD8. In contrast, the β -configuration that has the capacity
to activate PKC [21] decreased the levels of CD4 and CD8
Figure 1
Northern blot analysis of the effect of PMA and cAMP on
CD4 and CD8 mRNA levels in human thymocytes. Cells
were incubated for 4 h at 37°C in culture media as described
in the methods, in the absence (lane 1) or in the presence of
10 nM PMA (lane 2) or 1 mM dibutyryl cAMP plus 1 mM
IBMX (lane 3), and the combination of both (lane 4). RNA
was subsequently extracted and analyzed. The expression of
the proto-oncogene c-Ha-ras served as an internal control.
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mRNAs. The water-soluble phorbol 12,13 dibutyrate
(PDB) had similar effects to those of PMA. The specificity
of the signals driven by PMA was further stressed by the
up-regulation of CD3 expression and by the unaltered
mRNA levels of the proto-oncogene c-Ha-ras.
On the other hand, it has been previously demonstrated
that direct activation of adenylate cyclase by Forskolin or
cholera toxin, inhibition of cAMP-specific phosphodieste-
rase, and treatment with a cell permeable cAMP analog,
induces a rise in intracellular cAMP [22–26]. Since cAMP
is known to modulate the expression of CD8 in mice [27],
we sought to determine whether cAMP-dependent protein
kinase (PKA)-mediated signaling plays a role in modulat-
ing the mRNA levels of CD3, CD4, and CD8 in ex vivo ex-
amined human thymocytes. Fig. 3 shows that the signal,
which regulates the expression of human CD8, is cAMP-
mediated, since direct activation of adenylate cyclase by
cholera toxin produced the same effects as the di-butiryl
cAMP analog. The requirement of phosphodiesterase in-
hibition by IBMX further supports this statement. As it can
also be observed, cAMP coordinately regulated the expres-
sion of both the α  and β  chains of the CD8 molecule. CD4
remained unchanged and CD3 was minimally affected,
thus stressing the selectivity of the cAMP-dependent
down-regulation of CD8 expression (Fig. 3). To further in-
vestigate whether PMA and cAMP regulate CD4 and CD8
expression at the protein level, surface detection of the
CD3, CD4, and CD8 was also assessed. As observed in Fig.
4a PMA dropped the proportion of CD4+ cells from 60%
to zero, produced a slight decrease (from 71% to 64%) in
CD8+ cells, and did not affect the expression of CD3.
cAMP on the other hand had little effect on the surface ex-
pression of the glycoproteins. These findings are in con-
trast with the drastic down-regulation of CD8 transcript
levels exerted by cAMP. However, regulation gene expres-
sion is complex and engages numerous checkpoints that
include transcription, RNA processing, nuclear/cytosol
transport, translation, and RNA and Protein stability.
Since the half-lives of mRNA and protein can be dramati-
cally different, we hypothesize that an increased CD8 pro-
tein stability may result in a delay of CD8 surface
disappearance, thus favoring its transient selection. As
CD8 gene transcription has been turned-off by cAMP-me-
diated signaling, surface CD8 subsequently fades with the
concomitant emergence of CD4+ cells. In keeping with
this rationale, the kinetics of the PMA-mediated down-
regulation of CD4 (Fig. 4b) reveals a sharp and rapid de-
crease on CD4 surface expression as early as 15 min. of in-
cubation with PMA, with a complete disappearance by 2.0
hr. The relatively short kinetics of surface CD4 down-reg-
ulation and the delayed CD8 surface disappearance can be
interpreted as a PKC-mediated selection signaling in favor
of CD8+CD4-/α :β -TCR cells that may operate during in-
trathymic T cell differentiation. Binding of specific ligands
to CD4 (including phorbol esters) results in internaliza-
tion of the molecule by endocytosis, which in turn is
phosphorylated [28] and possibly immobilized. It is con-
ceivable that a similar mechanism might be used by extra-
cellular signals in the thymic epithelium during intrath-
ymic differentiation.
Discussion
An accepted scheme of the T cell development program
[29,30] has demonstrated that as immature cells enter the
thymus, cycling CD4-CD8- precursors begin to rearrange
δ , and γ  genes, which generates CD4-CD8-, and δ +γ + cells.
CD4+CD8+ on the other hand, rearrange and express the
α :β -TCR heterodimer. A few of these cells are selected
through the specificity of their antigen receptor and ma-
ture into either CD4+CD8-, or CD4-CD8+ T cells which
exit from the thymus.
Figure 2
Northern blot to determine the specificity of the Phorbol
ester effect on the expression of CD3, CD4, CD8, and C-
Ha-ras by human thymocytes. Experimental conditions are
number-coded as follows: 1 = control; 2 = PMA-treated;
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Much progress has been accomplished in determining the
molecular steps that lead to a better understanding of
murine T cell progenitor commitment and selection of the
functional repertoire, which has gained important in-
sights into mechanisms of CD4/CD8 lineage commit-
ment (reviewed in 31). For instance, changes in
expression of CD5, TCR, Bcl-2, RAG and TdT genes can be
induced by in vitro TCR engagement of DP thymocytes,
thus indicating that at least some aspects in the T cell mat-
uration program are directly coupled to TCR signaling. It
is therefore accepted that positive selection are directly
coupled to TCR signaling pathways in DP thymocytes.
However, the signals that promote selective down regula-
tion of CD4 and CD8 remain have not been that conclu-
sive, at least in humans. Earlier (again murine) studies
(reviewed in 31) have suggested that a transitional pheno-
type of CD4+ CD8low is not a signature of commitment
towards the CD4 lineage. The confirmation of such con-
clusion in the humans and the determination of the sig-
nals that lead to the phenotype remain to be assessed.
We have previously shown that PMA strongly induces the
transcription of α  and β  TCR in human thymocytes,
whereas cAMP exclusively affected the transcription of α -
TCR [15,16]. The data reported herein, suggest that fol-
lowing rearrangement, protein kinase C activation mim-
icked by the phorbol esters induces the expression of the
α  and β -TCR on CD4+CD8+ precursor T cells. Since only a
proportion of developing thymocytes succeed in express-
ing the α :β  TCR heterodimer, PKC activation also provides
the signal to turning off the CD4 and CD8 genes on cells
that failed to express the TCR, which are non-functional
and potentially harmful. On the other hand, cAMP is
known to participate in the growth and differentiation of
varied cell types (including thymocytes), through the tran-
scriptional regulation of specific genes [32–34]. The
unique cAMP signaling which specifically targets the ex-
pression of the CD8 mRNAs (α  and β ), suggests that PKA
activation may result in the transduction of signals that
determine the selection of T lymphocytes in favor of the
CD4+CD8- lineage, by down-regulating and possibly
turning off the expression of the CD8 transcripts. In keep-
ing with this notion, regulatory elements, within the CD4
and CD8 promoters have been identified an characterized
Figure 3
Northern blot to examine the effect of cyclic AMP analogs
and cholera toxin on CD4, CD8, and CD3 mRNA levels in
human thymocytes. Experimental conditions are number-
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Figure 4
Effect of PMA and cAMP on the surface expression of CD3,
CD4, and CD8 by human thymocytes. (a) Immunofluores-
cent staining and (b) CD4 surface expression kinetics. Exper-
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including the presence of cAMP regulatory elements bind-
ing (CREB) sites [35]. However it is also likely that the
control of CD4 and CD8 expression and thus the selection
of CD4 or CD8 lineage-committed cells may also be con-
trolled by the differences in mRNA and protein stability.
Lastly, some of the TCR signaling pathways involved in
positive selection have been identified in the mouse and
there is some evidence that these may be different from
those involved in negative selection. It remains to be de-
termined whether same interpretation applies to human T
cell selection.
Conclusion
In conclusion, the results of the ex vivo experiments of hu-
man thymocytes reported in the present study are in com-
plete agreement with the earlier studies in the murine
system and strongly support the conclusions. We further
propose that the transduction of intracellular signals initi-
ated by the activation of PKC and PKA by phorbol esters
and cAMP respectively, are not only critical for the differ-
ential regulation of CD4 and CD8 gene expression but
more importantly in the commitment and selection of the
functional T cell repertoire.
Materials and Methods
Cells
Human thymocytes were purified from fresh residual
thymic tissue that was obtained as an incidental specimen
from immunologially normal pediatric patients undergo-
ing cardiac surgery and according with institutional guide-
lines. Purification was carried out by a single step Ficoll/
Hypaque gradient centrifugation. Purified cells were cul-
tured at 37°C in RPMI-1640 medium supplemented with
10% fetal bovine serum at a density of 5 ×  106 cells/ml
and in the presence or absence of 10 nM PMA phorbol es-
ter and or 1 mM dibutyryl cAMP + 1 mM phosphodieste-
rase inhibitor isobutylemthylxnthine (IMBX).
Reagents
The phorbol esters 12-tetradecanoylphorbol-13 acetate
(PMA), 4x-phorbol, 12,13 didecanoate (α PD2), 4B-phor-
bol 12,13 didecanoate (β PD2), the phorbol 12,13 dibu-
tyrate (PDB), dibutyryl cyclic AMP, and the IBMX were
obtained from Sigma Chemical Co. (St. Louis, MO.).
Deionized formamide Distilled Phenol and guanidinium
isothiocyanate were purchased from Fluka (Milwaukee,
Wl). Nylon Hybond membranes (0.45 mm), and 32p-
dCTP were obtained from Amersham (Arlington Heights,
IL). The CD3 plasmid was commercially obtained from
the American Type Culture Collection (ATCC, Manassas,
VA) and the respective cDNA insert was generated by a Pst
I digestion. CD4 [36] and CD8 [37] were kind gifts from
Dr. Dan Littman and the respective cDNA probes were ob-
tained by digestion with the EcoR 1 restriction endonucle-
ase. The cHa-ras was also from ATCC and the respective
insert probe was excised by a Barn H1 endonuclease diges-
tion. The monoclonal antibodies to CD3, CD4, and CD8
were commercially obtained (Pharmigen, San Diego, CA).
RNA Extraction
Total unfractionated RNA was extracted in guanidiniun
isothiocyanate as previously described [38].
Northern Blots
Total RNA (10 µg) was electrophoresed in 1.0% agarose
gel and transferred onto nylon membranes as described
earlier [39,40]. Blots were then prehybridized overnight at
42°C in 50% formamide, 4X SSC, 5X Denhart's solution,
25 mM sodium phosphate, pH 6.5, 1.0% sodium deo-
decyi sulphate (SDS), and 200 µg/ml salmon sperm DNA.
Hybridization was carried out for 16 hr. at 42°C, simply
by adding [a-32P]dCTP-labeled probes. After hybridiza-
tion, northern blots were stringently washed for 2.0 hr.
and autoradiographed. Equal amounts of RNA loading of
the different experimental samples, was confirmed by
ethidium bromide staining and ultraviolet transillumina-
tor visualization. The constitutively expressed proto-onco-
gene c-Ha-ras was used as internal control.
Immunofluorescent Staining
Freshly isolated thymocytes were incubated in the pres-
ence or the absence of either PMA or cAMP+IBMX. At the
indicated times cells were harvested, washed twice with
phosphate-buffered saline (containing 0.1% serum bo-
vine albumin and 0.1% sodium azide), and incubated for
30 min at 4°C with specific monoclonal antibodies to ei-
ther CD3, CD4 or CD8. Cells were then washed twice with
PBS and incubated for 30 min at 4°C with the appropriate
FITC-conjugated second antibody. After the second incu-
bation the cells were washed twice with PBS and analyzed
on a fluorescence-activated Cell Sorter (FACS) II.
List of Abbreviations
IBMX: isobutylemthylxnthine/PMA: 12-tetradecanoyl-
phorboMS acetate/PKA: cAMP-dependent Protein Kinase/
PKC: Protein Kinase C
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